UT Tyler School of Medicine Professor Optimizes New Antibiotic Treatment for Lung Disease
April 10, 2026
April 10, 2026
TYLER, Texas, April 10 (TNSjou) -- The University of Texas Tyler campus issued the following news release:
* * *
UT Tyler School of Medicine Professor Optimizes New Antibiotic Treatment for Lung Disease
Dr. Shashikant Srivastava, a professor at The University of Texas at Tyler School of Medicine, optimized a new antibiotic combination for the treatment of Mycobacterium abscessus lung disease. His study was published in Antimicrobial Agents and Chemotherapy, . . .
* * *
UT Tyler School of Medicine Professor Optimizes New Antibiotic Treatment for Lung Disease
Dr. Shashikant Srivastava, a professor at The University of Texas at Tyler School of Medicine, optimized a new antibiotic combination for the treatment of Mycobacterium abscessus lung disease. His study was published in Antimicrobial Agents and Chemotherapy, . . .